2020
DOI: 10.1188/20.onf.417-427
|View full text |Cite
|
Sign up to set email alerts
|

Causes and Consequences of Chemotherapy Delays in Ambulatory Oncology Practices: A Multisite Qualitative Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 17 publications
0
6
0
Order By: Relevance
“…Possible reasons for this include the death of patients whilst on therapeutic intervention, their remission on completion of therapy, actual delays in treatment, and/or issues of affordability among patients with transport costs [ 45 , 78 , 79 ]. Treatment delays can also be due to laboratory testing processes, uncommunicated changes in day-of-treatment orders, discrepancies in care plans, delays of doctor instructions, and privation of covering to furnish for treatment financial outlay [ 80 ]. Overall, “14.9% of patients missed at least one scheduled appointment between March 2020 and December 2020 when the COVID-19” [ 60 ] constraints were in place, with similar outcomes regarding the pervasiveness of missed chemotherapy appointments.…”
Section: Discussionmentioning
confidence: 99%
“…Possible reasons for this include the death of patients whilst on therapeutic intervention, their remission on completion of therapy, actual delays in treatment, and/or issues of affordability among patients with transport costs [ 45 , 78 , 79 ]. Treatment delays can also be due to laboratory testing processes, uncommunicated changes in day-of-treatment orders, discrepancies in care plans, delays of doctor instructions, and privation of covering to furnish for treatment financial outlay [ 80 ]. Overall, “14.9% of patients missed at least one scheduled appointment between March 2020 and December 2020 when the COVID-19” [ 60 ] constraints were in place, with similar outcomes regarding the pervasiveness of missed chemotherapy appointments.…”
Section: Discussionmentioning
confidence: 99%
“…Care coordination has been previously highlighted as challenging to achieve across the patient journey, and this study extends the understanding of coordination in ambulatory settings [ 20 , 21 , 40 , 46 ]. Issues raised elsewhere, such as the potential for the receipt of conflicting information and poor information flow, were also relevant in these settings [ 20 , 23 , 24 ]. Professionals in the study were acutely aware of potential pitfalls (e.g., double-checking the accuracy of information) and formed proactive strategies, including extending their capacity, to mitigate these risks.…”
Section: Discussionmentioning
confidence: 99%
“…Coordination is an ongoing challenge across the patient journey [ 21 , 22 ]. Prior research indicates there may be a lack of delineation of the specific roles that health professionals play in the team, there can be poor information flow between providers, and conflicting information may be provided to patients [ 20 , 23 , 24 ]. The professional responsible for the coordination of care can change in the course of care.…”
Section: Introductionmentioning
confidence: 99%
“…As proposed by Marcus (2015) , multi-sited ethnography initially relied on immersive fieldwork. However, many recent multi-site ethnographies examine and contextualize care delivery in various organizations ( Côté-Boileau et al, 2020 ; Lafferty et al, 2020 ; Leighton et al, 2020 ; van Belle et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%